Exam 4 - Ott ADHD and PEDs Flashcards
When used in ASD, aripiprazole is 1/2 first line agents in ages _____ and used for _____
6-17 & irritability/aggression
When used in ASD, risperidone is 1/2 first line agents in ages _____ and used for _____
5-16 & irritability/aggression
what antidepressant is FDA approved to treat kids with depression down to 8 years old?
fluoxetine
what antidepressant is FDA approved to treat kids with depression 12-17 years old?
escitalopram
tx of depression in children step therapy
- non-pharm: family/caregiver support (necessary for success)
- cognitive behavioral therapy
- antidepressant medications
3.a. fluoxetine, escitalopram, sertraline
Peds PTSD tx step therapy
- Trauma-focused psychotherapy is 1st line tx
- SSRIs are 1st line drugs
aripiprazole - brand name
Abilify
asenapine - brand name
Saphris
brexpiprazole - brand name
Rexulti
lurasidone - brand name
Latuda
olanzapine - brand name
Zyprexa
olanzapine/fluoxetine - brand name
Symbyax
paliperidone - brand name
Invega
quetiapine - brand name
Seroquel
risperidone - brand name
Risperdal
(1) paliperidone - Diagnosis and age range
Schizophrenia - 12+
guanfacine ER - Brand name and CYP substrate
Intuniv (alpha-2-agonist)
-remember: 3A4 substrate
clonidine ER - Brand name
Kapvay (alpha-2-agonist)
what 2 drugs must you taper to avoid rebound HTN in peds ADHD
gaunfacine ER
clonidine ER
atomoxetine - Brand name
Strattera (norepi. reuptake inhibitor)
viloxazine - brand name
Qelbree (norepi. reuptake inhibitor)
atomoxetine - considerations
2D6 substrate
weightbased dosing
viloxazine - considerations
2D6/UGT substrate, 1A2 inhibitor
capsules, swallow whole or put in applesauce
norepi. reuptake inhibitor AE
increased HR and BP
boxed warning for increased suicidal thinking
alpha-2-agonist AE
decreased HR and BP
somnolence
dizziness
rebound HTN if abrupt DC
Bupropion - considerations
NOT FDA approved for ADHD but still used after other therapies tried if necessary
2D6 inhibitor
CI in seizure disorders and eating disorders
Tricyclic antidepressants - considerations
less effective than methylphenidate
sudden cardiac death may occur in children
atypical antipsychotics in ADHD
may be useful if there is a comorbid bipolar disorder, conduct disorder
should not be used as monotherapy
ADHD drug therapy considerations by age - preschool
1st line: methylphenidate
ADHD drug therapy considerations by age - elementary/middle school
1st line: stimulants
2nd line: atomoxetine, gaunfacine ER, Clonidine ER
_____% of children with ADHD will have diagnosis in adulthood
33
(increased/decreased) risk of substance use and antisocial personality disorder if ADHD is left untreated
increased
diagnostic criteria for ADHD (there are 4)
- for each Sx domain, must have at least 6 symptoms present
- for pts 18+, at least 5 Sx are required for either of the two specifiers
- several inattentive or hyperactive Sx must be present prior to age 12
- Sx present in 2 or more settings
stimulant dosing considerations (4)
- calculating weight based dosing not helpful
- IR preferred in pts weighing less than 16kg
- don’t use two different stimulants but can use 2 forms of one drug (long acting and short acting for example)
- late afternoon Sx may require long-acting formulation
Mydayis (mixed amphetamine salts) used in ages _____
13-17
Daytrana (methylphenidate) utilizes _____ dosage form
patch
Vyvanse (lisdexamphetamine) a _____ and converted to ______ via hepatic first pass metabolism
prodrug, dextroamphetamine
Jornay PM (methylphenidate HCl) should be taken what time of day?
take dose in evening between 6:30-9:30pm
Stimulant AE (11)
appetite loss (weight loss)
ab pain
HA
sleep distubrances
decreased growth
hallucinations or other psych Sx
Increased BP
Increased HR
sudden cardiac death
priapism
peripheral vasculopathy (Raynaud’s)
how to manage hallucination Sx caused by stimulant
DC stimulant, reassess diagnosis
how to manage risk for sudden cardiac death Sx caused by stimulant
assess risk of cardiac structural abnormality and family history
-if concern is present, cardiac ECHO can be done
age range for atypical antipsychotics in PEDS - schizophrenia
13+
age range for atypical antipsychotics in PEDS - Bipolar Disorder
10+